How much funding has Caris Life Sciences raised?

Caris Life Sciences has raised $1.5B in total funding, most recently a Growth Equity round.

Who are Caris Life Sciences's investors?

Caris Life Sciences's investors include OrbiMed, Sixth Street, Braidwell LP, Highland Capital Partners, TPG (Growth/Rise), Blue Owl Capital.

When was Caris Life Sciences founded?

Caris Life Sciences was founded in 2008.

Where is Caris Life Sciences headquartered?

Caris Life Sciences is headquartered in Irving, Texas, United States.

What industry is Caris Life Sciences in?

Caris Life Sciences operates in Diagnostics, Genomics, Healthcare, Life Sciences.

How many employees does Caris Life Sciences have?

Caris Life Sciences has 1001-5000 employees.

Caris Life Sciences

IPO

Where Molecular Science Meets Artificial Intelligence

Public · Irving, United States · Founded 2008 · $1.5B raised

Headquarters: Irving, Texas
Employees: 1001–5000
Founded: 2008
Business Model: B2B2C
Website: carislifesciences.com

Total Funding: $1.5B
Last Round: $168.0M Growth EquityApr 2025
Rounds: 4
Type: Public

About

Caris Life Sciences is a next-generation AI TechBio company and precision medicine pioneer delivering comprehensive molecular profiling of cancer at the DNA, RNA, and protein level. The company has built one of the world's largest multimodal databases with 740,000+ matched molecular and clinical outcomes records, applying AI and machine learning to classify cancer and predict patient response. Its products — MI Profile, MI Cancer Seek, Caris Assure, and AI signatures — support physicians, patients, and biopharma partners across the full care continuum.

Summary

Caris Life Sciences is a Diagnostics company based in Irving, United States, founded in 2008. It has raised $1.5B in total across 4 rounds, most recently a $168.0M Growth Equity round in Apr 2025. Investors include OrbiMed, Sixth Street and Braidwell LP.

LinkedIn X (Twitter)GitHub